Milestone Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.

About MIST

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. 

CEO
Joseph G. Oliveto
CEOJoseph G. Oliveto
Employees
29
Employees29
Headquarters
Montréal, Québec
HeadquartersMontréal, Québec
Founded
2003
Founded2003
Employees
29
Employees29

MIST Key Statistics

Market cap
170.74M
Market cap170.74M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
230.38K
Average volume230.38K
High today
High today
Low today
Low today
Open price
$4.94
Open price$4.94
Volume
0.00
Volume0.00
52 Week high
$9.85
52 Week high$9.85
52 Week low
$3.98
52 Week low$3.98

MIST Earnings

-$0.41
-$0.27
-$0.12
$0.02
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 23, Pre-Market
ActualExpected Mar 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.